Purpose: The purpose of this study was to study the influence of the minimum segment width (MSW) on volumetric modulated arc therapy (VMAT) plan quality, delivery accuracy, and efficiency for cervical cancer treatment.
| INTRODUCTION
Over the last decade, volumetric modulated arc therapy (VMAT) has been explored and implemented to treat a variety of cancers including in the prostate, head and neck, lung, and spine. [1] [2] [3] [4] VMAT is a dynamic treatment technique in which the radiation dose rates, gantry speeds, and movements of the multi-leaf collimator and jaws are simultaneously varied while the beam is on. 5 VMAT enables greater dose conformity to target tissues, and spares more of the normal tissue than traditional three-dimensional conformal radiation therapy (3D-CRT) and intensity-modulated radiation therapy (IMRT). [6] [7] [8] Generally, VMAT planning involves a two-step optimization procedure: First, ideal fluence maps are optimized and calculated according to an optimization algorithm; next, the arc sequencer algorithm converts these fluence maps to arc delivery maps while optimizing the multi-leaf collimator shape sequence to serial segments (control points). The minimum segment width (MSW) parameter takes an important role in the creation of the shapes and sizes of these segments. When designing VMAT plans to treat cervical cancer, optimization often results in some long and narrow segments that may have a notable impact on plan delivery, and can sometimes lead to a low verification passing rate and even an interruption. The impact of VMAT planning parameters, such as small monitor unit (MU) per segment, dose rate, and control point spacing, on plan quality have been evaluated for a Pinnacle 3 treatment planning system (TPS) using the Elekta Synergy/Varian Trilogy linear accelerator. 9, 10 However, there have been no reports regarding MSW optimization in terms of VMAT plan quality, delivery, accuracy, and efficiency.
The purpose of this study was to explore the influence of the MSW parameter on the quality and delivery accuracy of VMAT plans for cervical cancer to provide a useful reference for clinical treatment planning.
| MATERIALS AND METHODS

2.A | Patient selection
Nineteen patients with cervical cancer aged between 38 and 78 yr (average 52.6 yr) who underwent VMAT at our hospital between June 2017 and October 2017 were enrolled in this study. This study was approved by the Ethical Commission of our cancer center. Because this was not a treatment-based study, our institutional review board waived the need for written informed consent from the participants.
The patient information was anonymized and de-identified to protect patient confidentiality. 
2.B | Simulation and contouring
All patients were immobilized with a vacuum bag system with a supine position, and were then scanned using a Philips computed tomography (CT) simulator with a slice thickness of 3 mm. The reconstructed CT images were transmitted to Monaco 5.11 TPS.
Gross tumor volume (GTV) and clinical tumor volume (CTV) were delineated on CT images by an experienced radiation oncologist according to the institutional protocol. A contour expansion was applied to the GTV and CTV to delineate a planning target volume (PTV) that would receive 60 Gy (PTV60) and 45 Gy (PTV45). PTV60
was derived from the GTV with involved lymph nodes plus a uniform 5 mm margin, while the PTV45 was generated from the CTV plus a uniform 6-8 mm margin (Fig. 1 ). The bladder, rectum, spinal cord, kidneys, and femoral heads were delineated as organs at risk (OARs).
2.C | Treatment planning
For all patients, VMAT plans were designed using the Monaco TPS via the Monte Carlo (MC) algorithm, and plans were delivered using the Elekta Synergy linear accelerator with X ray beam energy (6 MV). Each case was planned with a single arc of 360°rotating clockwise from 181°to 179°. The collimator angle for each patient was fixed to 0°dur-ing gantry rotation, based on the patient's anatomy. The statistical uncertainty of the MC algorithm was 3% per control point, and the final dose was calculated with a calculation grid resolution of 3 mm.
The maximum number of control points was 150 for each plan. Three VMAT plans, 0.5 cm MSW, 1.0 cm MSW, and 1.5 cm MSW, were generated with MSWs of 0.5, 1.0, and 1.5 cm, respectively, while other parameters and cost functions remained unchanged. The prescription dose was the dose to 98% of the PTV60 (D98%) that received at least 60 Gy in 23 fractions. The cost functions are displayed in Table 1 .
2.D | Plan evaluation
The different MSW cervical plans were compared in terms of dosimetric indices such as the homogeneity index (HI), conformity index (CI), maximum dose of target volume, target coverage (TC), MUs, control points, and the DVH parameters concerning OARs. The TC and HI were determined as follows:
T A B L E 2 PTV dosimetric results of the VMAT plans used to treat 19 cervical cancer patients devised using three different MSWs. TCð%Þ ¼ ðTV PI =TVÞ Â 100
PTV
(1)
where TV PI represents the target volume receiving the prescription dose, TV represents the total target volume. D 5% is the minimum dose received by 5% of the PTV according to the DVH (indicating the maximum dose), and D 95% is the minimum dose received by 95% of the PTV (indicating the minimum dose). A lower HI represents better homogeneity.
The CI was calculated as below:
where V PI represents the total volume receiving the prescription dose (60 Gy or 45 Gy); the closer the CI is to 1, the more conformal is the target dose distribution.
Absolute dose distributions were measured using an Elekta corrections were performed for each image, and a time-integrated signal was obtained for every plan. The pixel values in the EPID images were reconstructed to dose values at a source to axis distance of 100 cm in the phantom. 11 The measured and computed doses were analyzed using RapiDose (Version 2.1, RayDose Inc.,
China) commercial software to analyze and calculate the gamma passing rate (GPR). 12 The plan delivery time (PDT; ie, the interval between beam activation and deactivation) was measured simultaneously for each plan.
2.E | Statistical analysis
The paired t-test followed by Bonferroni's correction was applied in the intergroup comparison for dosimetric parameters and measurement results using the SPSS 19.0 software. A p-value <0.05 indicated a statistically significant difference.
| RESULTS
3.A | Target doses
The target doses of the three VMAT plan groups are shown in Table 2 . The mean and maximum PTV60 and PTV45 doses were not markedly different among the three plans. The target dose coverage of the plan using an MSW of 0.5 cm was higher than that of the plan using an MSW of 1.0 cm, which in turn was better than that of the plan using an MSW of 1.5 cm. The DVH results using these three plans in a typical patient with cervical cancer are shown in T A B L E 4 Gamma passing rates and delivery times for plans with different minimum segment widths (MSWs). (p > 0.05). As for the PTV45, the 1.0 cm MSW plan had a lower HI than the 0.5 and 1.5 cm MSW plans.
3.B | OAR dose
OAR dose results are shown in Table 3 . Except for the lower maximum dose to the spinal cord when using the plan with the highest MSW, there were no significant differences between the three types of VMAT plans in terms of doses to the remaining OARs.
3.C | Control points and MUs
As the MSW value increased, the control points of the cervical cancer VMAT plan decreased; the mean number of control points for the plans with MSWs of 0.5, 1.0 and 1.5 cm were 137, 133, and 125, respectively (Fig. 4) . Moreover, the MUs of the VMAT plan decreased as the MSW increased ( 
3.D | Dosimetric verification and plan delivery time
Comparison between the measured planar dose and TPS-calculated dose was analyzed using the gamma passing criteria of a 2% dose difference (DD) and a 2 mm distance to agreement (DTA), as well as with passing criteria of a 3% DD and 3 mm DTA. Table 4 shows the GPRs for the 0.5, 1.0, and 1.5 cm MSW plans. The GPR was highest with the plan using a MSW of 1.5 cm and lowest in the plan using a MSW of 0.5 cm. Table 4 (Fig. 2) .
The measured and computed doses were analyzed using an EPID detector. All treatment plans showed good GPRs; the mean GPR was >94% when using the 3% DD and 3 mm DTA criteria, and >85% when using the 2% DD and 2 mm DTA criteria. 13 This showed that the measured dose was consistent with the calculated dose. The dose measured when using a higher MSW showed better agreement with the calculated dose from the TPS; this was expected given that the number of small fields decrease as the MSW increased, and dosimetric verification would therefore be relatively easier.
In addition, the number of control points and MUs decreased as the MSWs increased. When compared to the plan using a MSW of 0.5 cm, the mean MU reductions in the plans using MSWs of 1.0 and 1.5 cm were 15.2% and 21.9%, respectively, while the total control points were decreased by 2.9% and 8.8%, respectively. Previous studies showed that decreasing the MUs for treatment delivery reduces the constraint factor of the leaves' trajectories, complexity of intensity-modulated radiation therapy plans, and treatment time. [14] [15] [16] [17] Hence, as the MSW increases and VMAT plan complexity decreases, the therapeutic efficiency may improve as well. The average delivery times of the plans using MSWs of 1.0 and 1.5 cm were decreased by 9.6 and 19.2 s, respectively (a drop of approximately 3.6% and 7.3%, respectively), compared to the plan with a MSW of 0.5 cm.
| CONCLUSION
Generally, VMAT plans of cervical cancer that are generated with 
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